Vivo Bio Tech

Executive Summary

Vivo Bio Tech Ltd. is a leading Indian preclinical contract research organization (CRO) that has established itself as a trusted partner for global pharmaceutical, agrochemical, medical device, vaccine, nutraceutical, cosmetic, and industrial chemical companies. Operating from a 150,000 sq ft GLP-accredited campus in Hyderabad, the company offers comprehensive in-vivo and in-vitro toxicology, pharmacology, and analytical services. Its state-of-the-art SPF animal breeding facilities and broad test-system portfolio enable high-quality data generation for IND/NDA filings, ensuring acceptance by global regulatory authorities. Founded in 2000 and employing over 500 professionals, Vivo Bio Tech has built a reputation for reliability and scientific rigor. Despite being privately held with no public financial disclosures, its diversified service lines across multiple regulated industries position it as a resilient player in the contract research market. The company's focus on quality and compliance, evidenced by its GLP accreditation and specialized infrastructure, supports its long-term growth trajectory. As the demand for outsourced preclinical services rises, Vivo Bio Tech is well-placed to capture opportunities in both domestic and international markets.

Upcoming Catalysts (preview)

• Q3 2026Expansion of SPF animal facility and test system capabilities70% success
• TBDStrategic partnership with a top global pharmaceutical company for toxicology studies60% success
• Q3 2026Achievement of ISO 17025 or other international quality certifications80% success